What Is a CEP (Certificate of Suitability)?
A CEP (Certificate of Suitability) is an official document issued by the EDQM that certifies an active pharmaceutical ingredient (API) or excipient conforms to the quality standards outlined in the European Pharmacopoeia (Ph. Eur.).
It replaces the need to submit detailed substance data in each EU Marketing Authorization Application (MAA).
Why Is a CEP Important in the Pharmaceutical Industry?
A CEP simplifies and accelerates regulatory filings by proving the substance meets Ph. Eur. monograph standards. It’s:
- Globally recognized in the EU, Canada, Australia, Saudi Arabia, South Africa, Taiwan, and more.
- Trusted for GMP compliance, as EDQM inspections are often part of the approval process.
- A strategic asset for API manufacturers entering regulated markets with minimal duplication.
What Types of CEPs Exist?
According to EDQM and regulatory guidance, CEPs are granted for:
- Chemical APIs (Chemical CEP)
- Herbal APIs (Herbal CEP)
- TSE-Risk APIs (TSE CEP—covering transmissible spongiform encephalopathy risk)
- Combined CEPs: These may include combinations like Chemical + Sterility, Chemical + TSE, or Chemical + TSE + Sterility.
How Does the CEP Process Work?
- Application to EDQM: The manufacturer submits a dossier detailing substance specifications, manufacturing steps, controls, and supporting data.
- GMP Inspection: If needed, EDQM inspects the manufacturing site to verify alignment with quality standards.
- Evaluation Against Ph. Eur. Monograph: EDQM assesses whether the substance complies with the applicable monograph and issues a CEP if suitable.
- CEP 2.0 Format: The latest digital version enhances lifecycle tracking, database integration, and transparency across global submissions.
- Lifecycle Maintenance: The CEP holder must notify EDQM of significant changes and submit updates as required.
What Are Real-World Scenarios Where CEPs Are Used?
- Global API Supplier Seeking EU Access: A manufacturer in India obtains a CEP for its antihypertensive API, enabling multiple European clients to reference it in their MAAs without duplicating technical data.
- CMO Streamlining Multi-Client Filings: A CDMO producing a key excipient maintains a Type IV CEP, allowing various clients to submit EU filings without revealing proprietary manufacturing info.
- TSE CEP for Animal-Origin-Free Validation: A European firm producing collagen peptides secures a TSE CEP to demonstrate its product is free of bovine TSE risk.
- CEP as Competitive Advantage: A Chinese API manufacturer gains a competitive edge in ASEAN and LATAM markets by offering a Ph. Eur.-compliant product backed by a valid CEP.
Related Terms and Internal Links
- API Ingredients
- Excipient Sourcing
- DMF (Drug Master File)
- ASMF (Active Substance Master File) – EU equivalent to a DMF
- GMP Compliance
- EDQM Certification
Certificate of Suitability FAQs
What is a CEP used for in pharma?
A CEP certifies that a substance meets Ph. Eur. standards, allowing simplified regulatory filing across Europe and recognized global markets
Is a CEP the same as a DMF?
No. A CEP is a centralized EU certificate issued by EDQM, while a DMF is a confidential file submitted to regulators like the FDA.
Does a CEP ensure GMP compliance?
While not a substitute for GMP, EDQM may perform inspections, and GMP compliance is expected during evaluation.
Can one CEP be used across multiple filings?
Yes. A single CEP can be referenced by multiple sponsors and applications across regions that accept EDQM certification.
How long is a CEP valid?
Indefinitely—as long as it is kept current, and variations or updates are submitted when changes occur.